- Home
- / Innovent Biologics
Innovent Biologics
Stock Price
$37.2
2024-10-29
Market Capitalization
$57.6 B
2024-10-29
Revenue
¥13 B
FY, 2025
Innovent Biologics Summary
Company Summary
- Overview
- Innovent Biologics is a biopharmaceutical company that develops and manufactures drugs. It offers monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases.
- Type
- Public
- Status
- Active
- Founded
- 2011
- HQ
- Suzhou, CN | view all locations
- Website
- https://www.innoventbio.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Suzhou, Jiang Su Sheng HQ
China
No. 168, Dongping Street, Industrial Park
Innovent Biologics Financials
Summary Financials
- Revenue (FY, 2025)
- ¥13.0B
- Gross profit (FY, 2025)
- ¥12.0B
- Net income (FY, 2025)
- ¥813.6M
- Cash (FY, 2025)
- ¥17.3B
- EBIT (FY, 2025)
- ¥726.1M
- Enterprise value
- $43.1B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026